Related Experiment Video
Updated: Apr 6, 2026

13:27
Generation of Human CD40-activated B cells
Published on: October 17, 2009
15.8K
Human B lymphoma cell line producing B cell growth factor.
The Journal of Clinical Investigation
|February 1, 1985
Summary
A novel B cell growth factor produced by lymphoma cells promotes the proliferation of normal and cancerous B lymphocytes. This factor is distinct from known interleukins and interferons, suggesting a unique role in B cell malignancies.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- B cell lymphoma lines can produce factors influencing B cell growth.
- Understanding these factors is crucial for comprehending B cell malignancies and autonomous growth.
Purpose of the Study:
- To characterize a novel B cell growth factor produced by the Namalva lymphoma cell line.
- To investigate its effects on normal and malignant B lymphocytes.
- To differentiate this factor from known lymphokines.
Main Methods:
- Biochemical and physiological characterization of the secreted factor.
- Assays to measure the proliferation of normal activated human B lymphocytes and B cell lines.
- Comparative analysis with interleukin-1, interleukin-2, and interferon.
Main Results:
- Namalva cells secrete a factor (approx. 60 kDa) that enhances B lymphocyte proliferation.
- This factor stimulates both normal activated B cells and certain B cell lines.
- The factor is biochemically and physiologically distinct from IL-1, IL-2, and interferon.
Conclusions:
- Tumor-derived B cell growth factor may contribute to the autonomous growth of B cell lymphomas.
- This factor could play a role in the neoplastic potential of B cell tumors.
- The factor may also impact normal B cell populations in vivo.

